Catalyst Biosciences, Inc.
(NASDAQ : CBIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. 1.14%573.512.7%$658.89m
GILDGilead Sciences, Inc. -2.12%57.481.0%$565.42m
AMGNAmgen, Inc. -1.75%212.591.3%$557.09m
VRTXVertex Pharmaceuticals, Inc. 0.24%208.851.9%$535.47m
MRNAModerna, Inc. 3.29%67.900.0%$429.15m
ILMNIllumina, Inc. -0.23%308.973.5%$396.31m
EXASEXACT Sciences Corp. 0.57%128.2520.7%$299.30m
ALXNAlexion Pharmaceuticals, Inc. 3.00%118.292.0%$267.60m
BIIBBiogen, Inc. 0.46%245.391.7%$252.25m
NVAXNovavax, Inc. 1.70%82.7196.5%$242.41m
BNTXBioNTech SE 3.99%80.630.0%$206.05m
SRRKScholar Rock Holding Corp. -0.65%43.150.0%$173.85m
SGENSeagen Inc. 0.64%196.116.0%$145.89m
SRNESorrento Therapeutics, Inc. 1.98%7.231.4%$138.19m
CRSPCRISPR Therapeutics AG -0.04%94.680.6%$123.35m

Company Profile

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.